Elevance Health
1,173 hedge funds and large institutions have $69.9B invested in Elevance Health in 2020 Q4 according to their latest regulatory filings, with 167 funds opening new positions, 377 increasing their positions, 426 reducing their positions, and 76 closing their positions.
120% more first-time investments, than exits
New positions opened: 167 | Existing positions closed: 76
17% more capital invested
Capital invested by funds: $59.9B → $69.9B (+$10B)
7% more funds holding
Funds holding: 1,095 → 1,173 (+78)
0.07% less ownership
Funds ownership: 88.71% → 88.64% (-0.07%)
12% less repeat investments, than reductions
Existing positions increased: 377 | Existing positions reduced: 426
18% less funds holding in top 10
Funds holding in top 10: 28 → 23 (-5)
22% less call options, than puts
Call options by funds: $516M | Put options by funds: $660M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Optimal Asset Management
Los Altos,
California
|
+$786M |
| 2 |
Newport Trust Company
Washington,
District of Columbia
|
+$451M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$237M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$188M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$153M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$531M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$233M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$209M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$180M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$164M |
ELV Hedge Fund Activity: Q4 2020 in Review
1,173 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q4 2020, worth a combined $69.9B — up 17% from $59.9B a quarter earlier.
Buyers outnumbered sellers: 167 funds opened new ELV positions and 76 closed out — a net gain of 91 holders — while 377 added to existing stakes and 426 trimmed.
The largest buyer was Optimal Asset Management, adding an estimated $786M. The largest seller was T. Rowe Price Associates, cutting an estimated $531M.
- 1,173 institutional investors held Elevance Health (ELV) as of Q4 2020, up from 1,095 in Q3 2020.
- Funds reported $69.9B of Elevance Health stock for Q4 2020, up 17% quarter-over-quarter.
- 167 funds opened new Elevance Health positions in Q4 2020 and 76 closed out, a net change of +91 holders.
- The largest Elevance Health buyer in Q4 2020 was Optimal Asset Management, an estimated $786M added.
- The largest Elevance Health seller in Q4 2020 was T. Rowe Price Associates, an estimated $531M sold.
Based on aggregated 13F filings for Q4 2020.